ATPBD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.182800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.576480E-02
Normal-vs-Stage2
2.315400E-01
Normal-vs-Stage3
6.858400E-01
Normal-vs-Stage4
7.712000E-02
Stage1-vs-Stage2
3.340800E-01
Stage1-vs-Stage3
1.679780E-02
Stage1-vs-Stage4
6.546000E-01
Stage2-vs-Stage3
2.557200E-01
Stage2-vs-Stage4
2.236600E-01
Stage3-vs-Stage4
6.445600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.090000E-01
Normal-vs-AfricanAmerican
2.898000E-01
Normal-vs-Asian
5.390200E-01
Caucasian-vs-AfricanAmerican
9.477600E-01
Caucasian-vs-Asian
3.539400E-01
AfricanAmerican-vs-Asian
5.862800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.363200E-01
Normal-vs-Female
2.113800E-01
Male-vs-Female
7.788000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.449200E-01
Normal-vs-Age(41-60Yrs)
1.718370E-01
Normal-vs-Age(61-80Yrs)
2.620000E-01
Normal-vs-Age(81-100Yrs)
2.637000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.409600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.531000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.970000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.030000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.281400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.462800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.947780E-01
Normal-vs-Daily Drinker
2.854000E-01
Normal-vs-Weekly Drinker
3.965400E-01
Normal-vs-Occasional Drinker
1.518180E-01
Normal-vs-Social Drinker
1.847770E-01
Non Drinker-vs-Daily Drinker
6.983600E-01
Non Drinker-vs-Weekly Drinker
2.419600E-01
Non Drinker-vs-Occasional Drinker
9.676600E-01
Non Drinker-vs-Social Drinker
2.565400E-01
Daily Drinker-vs-Weekly Drinker
1.889390E-01
Daily Drinker-vs-Occasional Drinker
7.565600E-01
Daily Drinker-vs-Social Drinker
2.356600E-01
Weekly Drinker-vs-Occasional Drinker
2.265000E-01
Weekly Drinker-vs-Social Drinker
7.476400E-01
Occasional Drinker-vs-Social Drinker
2.920400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.716200E-02
Normal-vs-Grade 2
1.268220E-02
Normal-vs-Grade 3
2.927500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.197700E-02
Grade 1-vs-Grade 3
4.298100E-03
Grade 1-vs-Grade 4
2.716200E-02
Grade 2-vs-Grade 3
1.137640E-01
Grade 2-vs-Grade 4
1.268220E-02
Grade 3-vs-Grade 4
2.927500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.276800E-01
Normal-vs-NonDiabetic
2.247400E-01
Diabetic-vs-NonDiabetic
4.579600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.714100E-02
Normal-vs-NoPancreatitis
2.547800E-01
Pancreatitis-vs-NoPancreatitis
4.110200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.714010E-01
Normal-vs-N1
2.177200E-01
N0-vs-N1
7.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.763300E-04
Normal-vs-TP53-NonMutant
2.783400E-01
TP53-Mutant-vs-TP53-NonMutant
1.821320E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
